Bauya, Vanessa A.

HRN: 28-89-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2026
CO-AMOXICLAV 625MG (TAB)
04/23/2026
04/29/2026
PO
625mg
Q8h
Leukocytosis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: